Table 5 Risk factors for leprosy related ocular pathology (LROP)*.
Hazard ratio | SE | p Value | 95% CI | |
---|---|---|---|---|
Patient characteristics: | ||||
Age (per 10 years) | 1.100 | 0.125 | 0.403 | 0.880 to 1.374 |
Female v male | 0.584 | 0.246 | 0.202 | 0.256 to 1.334 |
Leprosy characteristics: | ||||
Classification | ||||
LL v BL | 0.657 | 0.296 | 0.350 | 0.272 to 1.586 |
Duration of disease | ||||
Duration ⩾1 year v <1 year | 1.296 | 0.440 | 0.445 | 0.666 to 2.521 |
Reaction | ||||
Type I reaction at enrolment | 1.359 | 0.524 | 0.426 | 0.638 to 2.893 |
Type II reaction at enrolment | 0.573 | 0.686 | 0.642 | 0.055 to 5.989 |
History of reactions | 0.871 | 0.420 | 0.775 | 0.339 to 2.241 |
History of face patch v no face patch | 0.879 | 0.295 | 0.701 | 0.455 to 1.698 |
Smear | ||||
Bacterial index at enrolment | 1.131 | 0.125 | 0.265 | 0.911 to 1.404 |
Smear positive v smear negative | 1.370 | 0.613 | 0.482 | 0.570 to 3.291 |
Deformity | ||||
Grade 2 deformity v no grade 2 deformity in all limbs | 3.371 | 2.461 | 0.096 | 0.806 to 14.098 |
*SE, standard error; 95% CI, 95% confidence interval; LROP includes muscle weakness, lagophthalmos, ectropion, entropion, trichiasis, episcleritis, scleritis, corneal nerve beading, punctate keratitis and uveal conditions; LL = Lepromatous leprosy, BL = Borderline lepromatous leprosy.